Association between the C-reactive protein-triglyceride glucose index and carotid atherosclerosis in patients with type 2 diabetes mellitus

Background The C-reactive protein-triglyceride glucose index (CTI), as a novel marker reflecting insulin resistance (IR) and inflammation, has been investigated in various diseases. However, the association of CTI with carotid atherosclerosis (CA) in patients with type 2 diabetes mellitus (T2DM) remains unclear. This study aimed to investigate the association between CTI and CA, which was assessed by carotid plaque and intima-media thickness (IMT) in patients with T2DM. Methods This retrospective cross-sectional study analyzed 938 patients with T2DM. The CTI was calculated using the formula: 0.412×Ln[CRP (mg/L)]+Ln[(TG (mmol/L)×88.57×FPG (mmol/L)×18.02)/2]. Logistic regression models were adopted to analyze the connection of CTI with carotid plaque, and linear regression models were used to explore the association of CTI with carotid IMT. Receiver operating characteristic (ROC) curves, integrated discrimination improvement (IDI), and net reclassification improvement (NRI) were used to assess discrimination and reclassification of prevalent carotid plaque. Results Among the 938 enrolled patients with T2DM, carotid plaques were detected in 438 participants (46.7%). Patients with carotid plaques had significantly higher CTI levels than those without plaques (9.98 ± 0.775 vs. 9.27 ± 0.664, P<0.001). After full adjustment, each one-unit increase in CTI was associated with higher odds of carotid plaque [odds ratio (OR) 4.189; 95% CI: 3.281-5.744; P<0.001] and greater carotid IMT (P = 0.016). When CTI was categorized into quartiles, compared with the lowest quartile, the highest quartile had an OR of 10.909 (95% CI: 6.982-17.521; P<0.001). The area under the ROC curve (AUC) showed superior discriminative performance of CTI for carotid plaque, with an AUC of 0.743, significantly higher than that of CRP (AUC 0.611; P<0.001) and the TyG index (AUC 0.655; P<0.001). When CTI was added to the base clinical model, the AUC increased from 0.737 to 0.820 (P<0.001), with an IDI of 13.5% and an NRI of 26.2%. Conclusion In patients with T2DM, elevated CTI levels are independently associated with the presence of carotid plaque and greater carotid IMT.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-06
DOI
https://doi.org/10.3389/fendo.2026.1991090
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between the C-reactive protein-triglyceride glucose index and carotid atherosclerosis in patients with type 2 diabetes mellitus

Yali Jing, Chengzi Wang, Yuan Zhang, Dan Liu
3 links
Frontiers in Endocrinology
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Association between the C-reactive protein-triglyceride glucose index and carotid atherosclerosis in patients with type 2 diabetes mellitus

Yali Jing, Chengzi Wang, Yuan Zhang, Dan Liu
article en

Abstract

Background The C-reactive protein-triglyceride glucose index (CTI), as a novel marker reflecting insulin resistance (IR) and inflammation, has been investigated in various diseases. However, the association of CTI with carotid atherosclerosis (CA) in patients with type 2 diabetes mellitus (T2DM) remains unclear. This study aimed to investigate the association between CTI and CA, which was assessed by carotid plaque and intima-media thickness (IMT) in patients with T2DM. Methods This retrospective cross-sectional study analyzed 938 patients with T2DM. The CTI was calculated using the formula: 0.412×Ln[CRP (mg/L)]+Ln[(TG (mmol/L)×88.57×FPG (mmol/L)×18.02)/2]. Logistic regression models were adopted to analyze the connection of CTI with carotid plaque, and linear regression models were used to explore the association of CTI with carotid IMT. Receiver operating characteristic (ROC) curves, integrated discrimination improvement (IDI), and net reclassification improvement (NRI) were used to assess discrimination and reclassification of prevalent carotid plaque. Results Among the 938 enrolled patients with T2DM, carotid plaques were detected in 438 participants (46.7%). Patients with carotid plaques had significantly higher CTI levels than those without plaques (9.98 ± 0.775 vs. 9.27 ± 0.664, P<0.001). After full adjustment, each one-unit increase in CTI was associated with higher odds of carotid plaque [odds ratio (OR) 4.189; 95% CI: 3.281-5.744; P<0.001] and greater carotid IMT (P = 0.016). When CTI was categorized into quartiles, compared with the lowest quartile, the highest quartile had an OR of 10.909 (95% CI: 6.982-17.521; P<0.001). The area under the ROC curve (AUC) showed superior discriminative performance of CTI for carotid plaque, with an AUC of 0.743, significantly higher than that of CRP (AUC 0.611; P<0.001) and the TyG index (AUC 0.655; P<0.001). When CTI was added to the base clinical model, the AUC increased from 0.737 to 0.820 (P<0.001), with an IDI of 13.5% and an NRI of 26.2%. Conclusion In patients with T2DM, elevated CTI levels are independently associated with the presence of carotid plaque and greater carotid IMT.

Frontiers in EndocrinologyVol. 17
Nanjing University of Chinese Medicine (CN), Nanjing Drum Tower Hospital (CN), Huazhong University of Science and Technology (CN)
Good health and well-being
Openalex Percentile: Top 13%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon